Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant. | Cold Spring Harb Mol Case Stud | 2021 | 33986034 | PubTator, text mining | PubMed |
| Whole genome sequencing of a snailfish from the Yap Trench (~7,000 m) clarifies the molecular mechanisms underlying adaptation to the deep sea. | PLoS Genet | 2021 | 33983934 | PubTator, text mining | PubMed |
| miRNA dysregulation is an emerging modulator of genomic instability. | Semin Cancer Biol | 2021 | 33979676 | PubTator, text mining | PubMed |
| Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions. | J Radiat Res | 2021 | 33978181 | PubTator, text mining | PubMed |
| XRCC2 repairs mitochondrial DNA damage and fuels malignant behavior in hepatocellular carcinoma. | Cancer Lett | 2021 | 33964350 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature. | Mol Genet Genomic Med | 2021 | 33960719 | PubTator, text mining | PubMed |
| Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers. | Genes (Basel) | 2021 | 33919281 | PubTator, text mining | PubMed |
| DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing. | Trends Genet | 2021 | 33896583 | PubTator, text mining | PubMed |
| Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence. | Oncol Lett | 2021 | 33868488 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Control of Cancer Stem Cell Characteristics in Endometrial Cancer by Network Analysis. | Comput Math Methods Med | 2021 | 33859719 | PubTator, text mining | PubMed |
| Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation. | Cold Spring Harb Mol Case Stud | 2021 | 33832919 | PubTator, text mining | PubMed |
| Integration of data across toxicity endpoints for improved safety assessment of chemicals: the example of carcinogenicity assessment. | Arch Toxicol | 2021 | 33830278 | PubTator, text mining | PubMed |
| Pilot Study to Detect Genes Involved in DNA Damage and Cancer in Humans: Potential Biomarkers of Exposure to E-Cigarette Aerosols. | Genes (Basel) | 2021 | 33809907 | PubTator, text mining | PubMed |
| Identification of Breast Cancer Subtype-Specific Biomarkers by Integrating Copy Number Alterations and Gene Expression Profiles. | Medicina (Kaunas) | 2021 | 33809336 | PubTator, text mining | PubMed |
| MiR-7 in Cancer Development. | Biomedicines | 2021 | 33806891 | PubTator, text mining | PubMed |
| Genetics of Azoospermia. | Int J Mol Sci | 2021 | 33806855 | PubTator, text mining | PubMed |
| Association of Polygenetic Risk Scores Related to Cell Differentiation and Inflammation with Thyroid Cancer Risk and Genetic Interaction with Dietary Intake. | Cancers (Basel) | 2021 | 33805984 | PubTator, text mining | PubMed |
| New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients. | Exp Oncol | 2021 | 33785725 | PubTator, text mining | PubMed |
| WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer. | Theranostics | 2021 | 33754029 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=28